Literature DB >> 27097369

MYC/miR-17-92 interplay maintains B-lymphoma cell homeostasis.

Marija Mihailovich1, Tiziana Bonaldi1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27097369      PMCID： PMC4889254          DOI： 10.1080/15384101.2016.1157977

Source DB:  PubMed          Journal:  Cell Cycle        ISSN： 1551-4005            Impact factor:   4.534


× No keyword cloud information.
  5 in total

1.  A microRNA polycistron as a potential human oncogene.

Authors:  Lin He; J Michael Thomson; Michael T Hemann; Eva Hernando-Monge; David Mu; Summer Goodson; Scott Powers; Carlos Cordon-Cardo; Scott W Lowe; Gregory J Hannon; Scott M Hammond
Journal:  Nature       Date:  2005-06-09       Impact factor: 49.962

2.  Feud or Friend? The Role of the miR-17-92 Cluster in Tumorigenesis.

Authors:  Jie Xiang; Ji Wu
Journal:  Curr Genomics       Date:  2010-04       Impact factor: 2.236

3.  The miR-17-5p microRNA is a key regulator of the G1/S phase cell cycle transition.

Authors:  Nicole Cloonan; Mellissa K Brown; Anita L Steptoe; Shivangi Wani; Wei Ling Chan; Alistair R R Forrest; Gabriel Kolle; Brian Gabrielli; Sean M Grimmond
Journal:  Genome Biol       Date:  2008-08-14       Impact factor: 13.583

4.  A component of the mir-17-92 polycistronic oncomir promotes oncogene-dependent apoptosis.

Authors:  Virginie Olive; Erich Sabio; Margaux J Bennett; Caitlin S De Jong; Anne Biton; James C McGann; Samantha K Greaney; Nicole M Sodir; Alicia Y Zhou; Asha Balakrishnan; Mona Foth; Micah A Luftig; Andrei Goga; Terence P Speed; Zhenyu Xuan; Gerard I Evan; Ying Wan; Alex C Minella; Lin He
Journal:  Elife       Date:  2013-10-15       Impact factor: 8.140

5.  miR-17-92 fine-tunes MYC expression and function to ensure optimal B cell lymphoma growth.

Authors:  Marija Mihailovich; Michael Bremang; Valeria Spadotto; Daniele Musiani; Elena Vitale; Gabriele Varano; Federico Zambelli; Francesco M Mancuso; David A Cairns; Giulio Pavesi; Stefano Casola; Tiziana Bonaldi
Journal:  Nat Commun       Date:  2015-11-10       Impact factor: 14.919
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.